Article source: eHealthNews.nz editor Rebecca McBeth
An Artificial Intelligence retinal screening tool, developed in New Zealand, is being used in 20 eye clinics in India and is about to launch in the United States.
THEIA has been created by Toku Eyes and provides diabetic screening to detect signs of eye disease. Clinical trials were held at Counties Manukau DHB in its central and satellite units, as well as a private optometrist in Palmerston North.
Co-founder Ehsan Vaghefi says the company has been working hard over the past year to convert the AI from a research tool into a medical product and it is now registered in India and the United States as such.